SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-17-021136
Filing Date
2017-03-16
Accepted
2017-03-16 17:12:27
Documents
2
Period of Report
2017-03-14

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 5719
2 POA DOCUMENT poa.txt EX-24.3_712497 3032
  Complete submission text file 0001209191-17-021136.txt   10088
Mailing Address 2225 COLORADO AVENUE SANTA MONICA CA 90404
Business Address 2225 COLORADO AVENUE SANTA MONICA CA 90404 (310) 824-9999
Kite Pharma, Inc. (Issuer) CIK: 0001510580 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O KITE PHARMA, INC. 2225 COLORADO AVENUE SANTA MONICA CA 90404
Business Address
WITTE OWEN N. (Reporting) CIK: 0001700969 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36508 | Film No.: 17695454